0001209191-20-004807.txt : 20200124
0001209191-20-004807.hdr.sgml : 20200124
20200124161012
ACCESSION NUMBER: 0001209191-20-004807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200122
FILED AS OF DATE: 20200124
DATE AS OF CHANGE: 20200124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martin Daniel C.
CENTRAL INDEX KEY: 0001752827
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 20545576
MAIL ADDRESS:
STREET 1: C/O DECIPHERA PHARMACEUTICALS, INC.
STREET 2: 500 TOTTEN POND ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-22
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001752827
Martin Daniel C.
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
0
1
0
0
Chief Commercial Officer
Common Stock
2020-01-22
4
M
0
26999
36.10
A
43999
D
Common Stock
2020-01-22
4
S
0
26999
67.1769
D
17000
D
Stock Option (Right to Buy)
36.10
2020-01-22
4
C
0
26999
0.00
D
2028-09-17
Common Stock
26999
63001
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the shares vested on September 18, 2019 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to continued service through such dates.
/s/ Jeffrey M. Held, Attorney-in-Fact
2020-01-24